Skip to main content
Rohit Bose, MD, Oncology, San Francisco, CA, UCSF Medical Center

RohitBoseMDPhD

Oncology San Francisco, CA

Genitourinary Oncology

Assistant Professor and Genitourinary Medical Oncologist at UCSF. Member of the Helen Diller Family Comprehensive Cancer Center.

Dr. Bose is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bose's full profile

Already have an account?

Summary

  • Dr. Rohit Bose is an oncologist at UCSF in San Francisco, CA. He received his medical degree from University of Toronto Faculty of Medicine and has been in practice 10 years. He specializes in genitourinary oncology and is experienced in prostate cancer.
  • Rohit Bose Lab @ UCSF

    The principal investigator of the lab is Rohit Bose MD PhD , assistant professor and practicing genitourinary medical oncologist at the UCSF Helen Diller Family

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2016
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2010
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2008, MD PhD

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2026
  • NY State Medical License
    NY State Medical License 2014 - 2018
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Merit Award, Genitourinary Cancers Symposium American Society of Clinical Oncology, 2016
  • Young Investigator Award Prostate Cancer Foundation, 2016
  • Physician Research Training Award US Department of Defense, Prostate Cancer Program, 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • ERF mutations reveal balance of positive and negative ETS factors controlling prostate cancer  
    Bose R, Karthaus W, Armenia J, Abida W, Iaquinta P, Wongvipat J, Wasmuth E, Shah N, Doran M, Wang P, Sullivan P, Patruno A, International SU2C/PCF Prostate Cancer Drea..., Nature, 1/1/2017
  • Income and spending patterns among panhandlers  
    Bose, R. and Hwang, S.W., Canadian Medical Association Journal, 1/1/2002
  • Spectroscopic characterization by laser flash photolysis of electrophilic intermediates derived from 4-aminostilbenes Stilbene nitrenium ions and quinone methide imines  
    Bose, R., Ahmad, A., Dicks, A., Kayser, K. and McClelland, R., Perkin Transactions, 1/1/1999

Books/Book Chapters

Abstracts/Posters

  • Randomized Phase IB/II Study of Enzalutamide with and without Ribociclib in Patients with Metastatic Castrate Resistant, Chemotherapy Naive Prostate Cancer that Retain...
    Kelly, W, Godwin J, Hoffman-Censits J, Knudsen K, De Leeuw R, Leiby B, Southwell T, Hubert C, Smith D, Chatta G, Aghalar J, Scher H, Bose R, Autio K, Abida W, Slovin S..., GU ASCO, San Francisco, 1/1/2018

Press Mentions

  • $35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSF
    $35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSFOctober 10th, 2019
  • UCSF Launches New Initiative to Accelerate Prostate Cancer Research
    UCSF Launches New Initiative to Accelerate Prostate Cancer ResearchSeptember 23rd, 2019
  • Researchers Unravel the Biology of a Distinct Prostate Cancer Subtype
    Researchers Unravel the Biology of a Distinct Prostate Cancer SubtypeJune 26th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations